MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst Fluid

Antigens in hydatid cyst fluid (HCF) have been discovered to bear a significant resemblance to antigens present in cancer cells. MicroRNA-1 (miR-1) is a well-known member of the tumor inhibitor miRNA family and has been shown to have pro-apoptotic and tumor-inhibitory functions. This study aimed to...

Full description

Bibliographic Details
Main Authors: Hadis Jafari, Mahmoud Mahami-Oskouei, Adel Spotin, Behzad Baradaran, Dariush Shanehbandi, Amir Baghbanzadeh, Zahra Alizadeh
Format: Article
Language:English
Published: Hindawi Limited 2024-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2024/7474039
_version_ 1797256737378533376
author Hadis Jafari
Mahmoud Mahami-Oskouei
Adel Spotin
Behzad Baradaran
Dariush Shanehbandi
Amir Baghbanzadeh
Zahra Alizadeh
author_facet Hadis Jafari
Mahmoud Mahami-Oskouei
Adel Spotin
Behzad Baradaran
Dariush Shanehbandi
Amir Baghbanzadeh
Zahra Alizadeh
author_sort Hadis Jafari
collection DOAJ
description Antigens in hydatid cyst fluid (HCF) have been discovered to bear a significant resemblance to antigens present in cancer cells. MicroRNA-1 (miR-1) is a well-known member of the tumor inhibitor miRNA family and has been shown to have pro-apoptotic and tumor-inhibitory functions. This study aimed to evaluate the ability of HCF to prevent breast cancer and to explore the underlying mechanisms that affect cancer cells. For this study, MDA-MB-231 and MCF-7 breast cancer cells were cultured and divided into two groups: one group received HCF treatment and the other group was untreated and served as the control group. The cytotoxicity and cell viability of various HCF concentrations on breast cancer cells were evaluated using the MTT assay. In addition, the expression level of miR-1 in HCF-treated and untreated breast cancer cells was analyzed using qRT-PCR. The study found that HCF treatment reduced the growth of MDA-MB-231 and MCF-7 breast cancer cells, indicating that it was cytotoxic to the cells. Specifically, the IC50 concentration of HCF after 24 hours of treatment was 7.32 µg/mL for MDA-MB-231 cells and 13.63 µg/mL for MCF-7 cells. In addition, qRT-PCR analysis revealed that the expression level of miR-1 was significantly increased in HCF-treated MDA-MB-231 (P=0.0203) and MCF-7 (P=0.0394) cell lines compared to untreated controls. Although HCF has been shown to inhibit the growth of breast cancer cells and to upregulate miR-1, a key tumor suppressor in cancer cells, the specific mechanisms responsible for this effect remain unclear. Further studies are needed to fully understand the molecular pathways underlying HCF’s antitumor activity and its potential as a therapeutic agent in cancer therapy.
first_indexed 2024-04-24T22:26:30Z
format Article
id doaj.art-bc7f87c5e23f41a9a080efffa87bf7be
institution Directory Open Access Journal
issn 1687-9694
language English
last_indexed 2024-04-24T22:26:30Z
publishDate 2024-01-01
publisher Hindawi Limited
record_format Article
series Journal of Tropical Medicine
spelling doaj.art-bc7f87c5e23f41a9a080efffa87bf7be2024-03-20T00:00:00ZengHindawi LimitedJournal of Tropical Medicine1687-96942024-01-01202410.1155/2024/7474039MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst FluidHadis Jafari0Mahmoud Mahami-Oskouei1Adel Spotin2Behzad Baradaran3Dariush Shanehbandi4Amir Baghbanzadeh5Zahra Alizadeh6Immunology Research CenterImmunology Research CenterDepartment of Parasitology and MycologyImmunology Research CenterImmunology Research CenterImmunology Research CenterDepartment of Parasitology and MycologyAntigens in hydatid cyst fluid (HCF) have been discovered to bear a significant resemblance to antigens present in cancer cells. MicroRNA-1 (miR-1) is a well-known member of the tumor inhibitor miRNA family and has been shown to have pro-apoptotic and tumor-inhibitory functions. This study aimed to evaluate the ability of HCF to prevent breast cancer and to explore the underlying mechanisms that affect cancer cells. For this study, MDA-MB-231 and MCF-7 breast cancer cells were cultured and divided into two groups: one group received HCF treatment and the other group was untreated and served as the control group. The cytotoxicity and cell viability of various HCF concentrations on breast cancer cells were evaluated using the MTT assay. In addition, the expression level of miR-1 in HCF-treated and untreated breast cancer cells was analyzed using qRT-PCR. The study found that HCF treatment reduced the growth of MDA-MB-231 and MCF-7 breast cancer cells, indicating that it was cytotoxic to the cells. Specifically, the IC50 concentration of HCF after 24 hours of treatment was 7.32 µg/mL for MDA-MB-231 cells and 13.63 µg/mL for MCF-7 cells. In addition, qRT-PCR analysis revealed that the expression level of miR-1 was significantly increased in HCF-treated MDA-MB-231 (P=0.0203) and MCF-7 (P=0.0394) cell lines compared to untreated controls. Although HCF has been shown to inhibit the growth of breast cancer cells and to upregulate miR-1, a key tumor suppressor in cancer cells, the specific mechanisms responsible for this effect remain unclear. Further studies are needed to fully understand the molecular pathways underlying HCF’s antitumor activity and its potential as a therapeutic agent in cancer therapy.http://dx.doi.org/10.1155/2024/7474039
spellingShingle Hadis Jafari
Mahmoud Mahami-Oskouei
Adel Spotin
Behzad Baradaran
Dariush Shanehbandi
Amir Baghbanzadeh
Zahra Alizadeh
MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst Fluid
Journal of Tropical Medicine
title MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst Fluid
title_full MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst Fluid
title_fullStr MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst Fluid
title_full_unstemmed MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst Fluid
title_short MicroRNA-1 Inhibits the Growth of Breast Cancer Cells MDA-MB-231 and MCF-7 Treated with Hydatid Cyst Fluid
title_sort microrna 1 inhibits the growth of breast cancer cells mda mb 231 and mcf 7 treated with hydatid cyst fluid
url http://dx.doi.org/10.1155/2024/7474039
work_keys_str_mv AT hadisjafari microrna1inhibitsthegrowthofbreastcancercellsmdamb231andmcf7treatedwithhydatidcystfluid
AT mahmoudmahamioskouei microrna1inhibitsthegrowthofbreastcancercellsmdamb231andmcf7treatedwithhydatidcystfluid
AT adelspotin microrna1inhibitsthegrowthofbreastcancercellsmdamb231andmcf7treatedwithhydatidcystfluid
AT behzadbaradaran microrna1inhibitsthegrowthofbreastcancercellsmdamb231andmcf7treatedwithhydatidcystfluid
AT dariushshanehbandi microrna1inhibitsthegrowthofbreastcancercellsmdamb231andmcf7treatedwithhydatidcystfluid
AT amirbaghbanzadeh microrna1inhibitsthegrowthofbreastcancercellsmdamb231andmcf7treatedwithhydatidcystfluid
AT zahraalizadeh microrna1inhibitsthegrowthofbreastcancercellsmdamb231andmcf7treatedwithhydatidcystfluid